These findings suggest that AURKA-mediated phosphorylation of ALDH1A1 considerably contributes to the drug resistance observed in patients with pancreatic ductal adenocarcinoma (PDAC). This evidence concerns the gene ALDH1A1 and pancreatic ductal adenocarcinoma.